Bladder Cancer Trial, Recruiting (NCT05739968)

Bladder Cancer Trial, Recruiting NCT05739968 Sponsor: National Taiwan University Hospital Condition: Bladder Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05739968 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Bladder Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 20 years or older
People who have been newly diagnosed with a type of bladder cancer that has not grown into the muscle layer of the bladder, and whose bladder has not been surgically removed
People who are able to speak and communicate verbally with others
People who can read and speak Mandarin or Chinese

Who may not be able to join:

People whose bladder cancer cannot be treated with surgery
People who have been diagnosed with a more advanced type of bladder cancer that has grown into the muscle layer of the bladder, where bladder removal surgery is planned
People whose primary cancer origin is unknown
People who are not fully conscious or have unclear awareness (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 15 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yeur-Hur Lai, Professor, School of Nursing, College of Medicine, National Taiwan University

Phone: 886-2-23123456

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05739968

Sponsor: National Taiwan University Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Bladder Cancer

Trial contact: 886-2-23123456

More information: https://clinicaltrials.gov/study/NCT05739968

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 20 years or older
People who have been newly diagnosed with a type of bladder cancer that has not grown into the muscle layer of the bladder, and whose bladder has not been surgically removed
People who are able to speak and communicate verbally with others
People who can read and speak Mandarin or Chinese

Who may not be able to join:

People whose bladder cancer cannot be treated with surgery
People who have been diagnosed with a more advanced type of bladder cancer that has grown into the muscle layer of the bladder, where bladder removal surgery is planned
People whose primary cancer origin is unknown
People who are not fully conscious or have unclear awareness (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 15 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

National Taiwan University Hospital

Registry

ClinicalTrials.gov

Start date

1 April 2021

Est. completion

31 December 2025

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Changes in Quality of Life (consisting of symptoms, function, and health status); Changes in Anxiety; Changes in Depression; Changes in Fear of Cancer Recurrence; Changes in Sleep Quality (consisting of sleep duration, sleep disturbances, sleep latency, daytime functioning, habitual sleep efficiency, subjective sleep quality, and sleep medication); Changes in Physical Activity; Changes in Nutrition Status; Changes in Balance; Changes in Muscle strength and Endurance in Upper Limbs; Changes in Muscle strength and Endurance in Lower Limbs; Changes in Functional Mobility

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov